Compounded semaglutide
Sold by Bon Health · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$230
| Medication · Monthly | $230 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Monthly “Rx · Popular Compounded Semaglutide Weekly self-injection. Works on appetite signaling to steady hunger and cravings. Titrated by your doctor across the program. $ 230 /mo” source, read September 2, 2026 | Per month$230 | Charged today$230 |
We earn nothing from this link. Bon Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $230
- September 3, 2026 — $230
- September 3, 2026 — States changed
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | Not disclosed |
|---|---|
| Cancellation | “Cancel anytime” |
| Membership | None. “Bon Health charges no membership fee - the per-month price for your chosen commitment tier is what you pay, billed monthly or quarterly depending on the plan you select.” |
Not yet checked: pharmacy, prescriber and consult fee.
Recorded from bonhealth.io. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Bon Health is explicit that its per-drug prices already include everything: '$0 Membership fee. Your medication price is your final price.' and '† Prices reflect medication only. No membership fee. Cancel anytime.' The compounded-tirzepatide product page is where the four commitment tiers (monthly/3-month/6-month/annual) are shown in full; the compounded-semaglutide tab only exposed one static monthly price ($230/mo) in this tool's output, its own tiered breakdown was not recoverable. Brand-name product tiles (Wegovy/Ozempic/Zepbound/Mounjaro, listed as 'Compounded name-brand GLP-1 therapies' despite being FDA-approved brand products) give real cash prices; No form (vial/pen) is stated for any product on this page, compounded or brand, so all entries use not-disclosed; no explicit sync/async statement was found either.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.